We are live on
!
Find out more
CA
Corriente Advisors Portfolio holdings
AUM
$9.53M
1-Year Est. Return
805.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.54%
1 Year Est. Return
+805.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8M
AUM Growth
-$134M
(-72%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-264.65%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
21
New
6
Increased
–
Reduced
2
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
+$8.66M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$7.57M |
| 3 |
Vermilion Energy
VET
|
+$5.12M |
| 4 |
Cenovus Energy
CVE
|
+$4.61M |
| 5 |
Cameco
CCJ
|
+$378K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$76.7M |
| 2 |
Replimune Group
REPL
|
+$17.3M |
| 3 |
Coinbase
COIN
|
+$10.1M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.1M |
| 5 |
QuantumScape Corp
QS
|
+$9.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.39% |
| 2 | Energy | 41.26% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cue Biopharma
CUE
$131M
| $13.8M | 26.68% |
31,613
-17,953
| -36% | -$6.26M |
|
|
SWN
2
DELISTED
Southwestern Energy Company
SWN
| $8.59M | 16.58% |
+1,550,000
| New | +$7.57M |
|
|
TFFP
3
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $7.87M | 15.2% |
+40,794
| New | +$8.66M |
|
4
Lantern Pharma
LTRN
$36.6M
| $7M | 13.51% |
625,873
-30,491
| -5% | -$395K |
|
|
5
Vermilion Energy
VET
$1.51B
| $6.91M | 13.34% |
+700,000
| New | +$5.12M |
|
|
6
Cenovus Energy
CVE
$52.1B
| $5.44M | 10.5% |
+540,000
| New | +$4.61M |
|
|
7
Cameco
CCJ
$37.3B
| $435K | 0.84% |
+20,000
| New | +$378K |
|
|
8
Coinbase
COIN
$41.4B
| – | – |
-40,000
| Closed | -$10.1M |
|
9
Cardiff Oncology
CRDF
$60.2M
| – | – |
-1,383,500
| Closed | -$9.2M |
|
10
CRISPR Therapeutics
CRSP
$4.71B
| – | – |
-20,000
| Closed | -$3.24M |
|
11
DiaMedica Therapeutics
DMAC
$393M
| – | – |
-203,641
| Closed | -$906K |
|
|
HIMX
12
Himax Technologies
HIMX
$2.23B
| – | – |
-200,000
| Closed | -$3.33M |
|
13
Iridium Communications
IRDM
$4.95B
| – | – |
-80,000
| Closed | -$3.2M |
|
14
Kratos Defense & Security Solutions
KTOS
$8.63B
| – | – |
-275,738
| Closed | -$7.86M |
|
15
MP Materials
MP
$8.05B
| – | – |
-110,000
| Closed | -$4.05M |
|
|
16
QuantumScape Corp
QS
$3.6B
| – | – |
-337,316
| Closed | -$9.87M |
|
17
Roblox
RBLX
$37B
| – | – |
-30,000
| Closed | -$2.7M |
|
|
18
Replimune Group
REPL
$859M
| – | – |
-449,879
| Closed | -$17.3M |
|
|
RETA
19
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-71,115
| Closed | -$10.1M |
|
|
MAXR
20
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| – | – |
-1,920,333
| Closed | -$76.7M |
|
Similar funds
SCM
FWM
TOPU
TGI
GIP
LCMP
SCM
TA
Corriente Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Corriente Advisors held 21 positions worth $51.8M, down 72% from $185M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Corriente Advisors withdrew a net $137M in Q3 2021, closing 13 positions and reducing 2 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $76.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 36% a quarter earlier, followed by Energy and Financials.
Against the trend, Corriente Advisors opened a new position in TFF Pharmaceuticals, Inc. Common Stock worth $7.87M.
- Corriente Advisors's largest Q3 2021 buy was TFF Pharmaceuticals, Inc. Common Stock: 40,794 shares worth $7.87M.
- Corriente Advisors's biggest Q3 2021 reduction was Cue Biopharma, cutting an estimated $6.26M.
- Corriente Advisors fully exited Maxar Technologies Inc. Common Stock in Q3 2021, selling an estimated $76.7M.
- Corriente Advisors's ten largest holdings make up 100% of its $51.8M portfolio in Q3 2021.
- Corriente Advisors opened 6 new positions and closed 13 in Q3 2021.
- Corriente Advisors's portfolio value fell 72% quarter-over-quarter to $51.8M.
Based on Corriente Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.